11101
Full Member
- Joined
- Aug 26, 2014
- Messages
- 21,554
As I am writing these posts someone just sent me this.
https://www.medrxiv.org/content/10.1101/2021.08.06.21261707v1.full.pdf
Argues in favor of Moderna over Pfizer and notes decreased efficacy in July likely due to higher delta. Interesting. Don't have time to read the whole article. But will look out for discussion on this.
There are a couple of these studies coming out which suggest similar, though the difference is small. Could be due to the larger dose given in Moderna?
As a company, Moderna do nothing else but mRNA and this is their first and only product. This quote from their last earnings kind of sums them up:
Total revenue was $4.4 billion for the three months ended June 30, 2021, compared to $67 million for the same period in 2020.
They've gone from a small, loss making research house to a multi billion dollar company overnight. You'd imagine they're pretty good at mRNA but at the same time they don't have anywhere near Pfizer's expertise in scaling up production.